Human papilloma virus vaccination provides long-term protection

25 septiembre 2014

Persistent infection with a high-risk human papillomavirus (HPV) type is a necessary prerequisite for the development of dysplasia and neoplasia of the cervix, precursors to cervical cancer. The HPV vaccination has been a subject of heated debate since it was launched. Now researchers have produced a systematic review that shows no decrease in protection over a period of five years following vaccination against HPV types 16 and 18.